Skip to main content
. Author manuscript; available in PMC: 2020 Jul 21.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2015 Sep 16;94(1):118–125. doi: 10.1016/j.ijrobp.2015.09.011

Table 1.

Eligibility/Exclusion Criteria

Eligibility Exclusion
Age ≥18 years old Breast micro-calcifications prior to starting radiation treatment (RT)
ECOG performance status of 0–1 > 9 positive axillary or sentinel lymph node
Stage 0–IIIA (pTis-T2, pN0-pN2a, M0) breast cancer Lobular carcinoma in situ alone or non breast epithelial histology
Systemic treatment (chemotherapy or hormonal therapy) was allowed. Multicentric disease
Neoadjuvant chemotherapy allowed. Clinically or radiographically suspicious contralateral regional lymph nodes unless histologically confirmed negative for tumor
Negative margins (no tumor on ink). Prior treatment for contralateral or synchronous breast cancer or if they had prior RT to the current breast.
Co-morbid conditions:
  • Paget’s disease

  • Collagen vascular disease

  • Life expectancy <2 years secondary to co-morbidities

  • Psychiatric or addictive disorder that precluded informed consent

  • Malignancy other than non-melanomatous skin cancer < 5 years prior to enrollment

No documented negative pregnancy test or unwilling to maintain safe and effective birth control